Citicoline

Product Information:

OtherNames: Cognizin,cdp-cholin, cdp-colina,citidindifosfatodecolina, cytidindiphosphocholin

Source:Fermented from cytidic acid

Assay: >98%

Appearance:White powder

CAS No.: 987-78-0
EINECS:213-580-7

Molecular formula:C14H26N4O11P2

Molecular weight:448.32

Heavy metals: <10PPM

JP grade

ProductDescription:

Citicoline(Cognizin), a nucleoside derivative, can improve the state of consciousness and EEG of disturbance of consciousness after head trauma or brain surgery, and promote the recovery of upper limb motor function in hemiplegic patients with stroke. It plays a certain role in promoting the recovery of brain function and awakening.
Promotes lecithin biosynthesis and antiphospholipase A.

Used in combination with proteolytic enzyme inhibitors to protect and repair pancreatic tissue.

Uses, benefits, Side Effects

1. For acute craniocerebral injury and consciousness disturbance after brain operation. Cerebral thrombosis, multiple cerebral embolism, tremor paralysis, apoplexy sequelae, cerebral arteriosclerosis caused by cerebral insufficiency of blood supply, hypnotic drugs and carbon monoxide poisoning and various organic encephalopathy.

2. The product is a precursor of ovalosate biosynthesis, which can promote the biosynthesis of lecithin. This product can promote the recovery and awakening of brain function. Suitable for brain trauma, stroke sequelae and other consciousness disorders, but also for central nervous system acute injury caused by consciousness disorders.

No side effects known in the concentrations used.

Application

This products can be widely applied in Nutritional supplement, nutrition enhancer, dietary supplements, heatlh food additives, pharmaceutical raw materialindustry etc.